These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7545724)

  • 1. Quality of life, voiding symptoms and uroflowmetry in healthy males and benign prostatic hyperplasia (BPH) patients.
    Batista JE; Regalado R; Araño P; Vicente J
    J Urol (Paris); 1995; 101(1):3-6. PubMed ID: 7545724
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
    Unsal A; Cimentepe E
    Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of transurethral resection of prostate on quality of life in aged patients with benign prostatic hyperplasia].
    Cheng NZ; Tang ZY; Liu Y; Liu XS; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):975-8. PubMed ID: 19001744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life assessment of the male with benign prostate hypertrophy].
    Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
    Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance and variability of the severity of incontinence, and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms.
    Haltbakk J; Hanestad BR; Hunskaar S
    BJU Int; 2005 Jul; 96(1):83-7. PubMed ID: 15963126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symptoms and signs of benign prostate hypertrophy (BPH)].
    Imai K; Kurokawa K; Sekihara T; Suzuki T; Yamanaka H; Takahashi H; Mashimo T; Takahashi O; Kitaura K; Saruki K
    Hinyokika Kiyo; 1993 Jan; 39(1):15-22. PubMed ID: 7681620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress in the medical treatment of benign prostatic hyperplasia].
    Cornu JN; Rouprêt M
    Prog Urol; 2007 Sep; 17(5 Suppl 1):1029-32. PubMed ID: 17969785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Van Venrooij GE; Eckhardt MD; Boon TA
    Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum flow rate--the single uroflowmetric parameter in clinical trials for benign prostatic hyperplasia?
    Homma Y; Imajo C; Kawabe K
    Int J Urol; 1995 Nov; 2(5):322-5. PubMed ID: 8749951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
    Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
    J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of benign prostatic hyperplasia.
    Lee C; Kozlowski JM; Grayhack JT
    Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
    Gesenberg A; Sintermann R
    J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
    Takahashi S; Tajima A; Matsushima H; Kawamura T; Tominaga T; Kitamura T
    Int J Urol; 2006 Jan; 13(1):15-20. PubMed ID: 16448426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of symptoms in patients with benign prostatic hyperplasia].
    Cornu JN; Rouprêt M
    Prog Urol; 2007 Sep; 17(5 Suppl 1):1023-5. PubMed ID: 17969783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tonocardin (doxazosin) in treating lower urinary tract symptoms].
    Mazo EB; Chepurov DA
    Urologiia; 2003; (3):15-6. PubMed ID: 12846089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
    Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.
    O'Sullivan M; Murphy C; Deasy C; Iohom G; Kiely EA; Shorten G
    J Am Coll Surg; 2004 Mar; 198(3):394-403. PubMed ID: 14992742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical results of interstitial laser coagulation for benign prostatic hyperplasia using diode laser].
    Kin S; Kanatani I; Konami T
    Hinyokika Kiyo; 1999 Nov; 45(11):749-53. PubMed ID: 10637736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.